Suppressing "bad" LDL cholesterol promotes cancer!

Low-Density Lipoprotein (LDL) cholesterol – called by medical establishment "bad" cholesterol, and is the major target of the multi-billion dollar statin drugs industry – protects us against cancer. People with naturally low levels of LDL cholesterol are more likely to develop cancer over their lifetime, new research has suggested.
The discovery, from Tufts Medical Center, adds to the growing list of health benefits of LDL cholesterol, which contradicts of medicine establishment believes, that it blocks arteries, and causes heart disease.
It`s already known that it protects the brain as we age, and that low levels can escalate problems such as dementia and memory loss.
Dr. Paul Lavigne said (at the American College of Cardiology 2012 Scientific Sessions) that association between serum cholesterol levels and cancer incidence was first documented more than 30 years ago. More recently, a 2007 meta-analysis by Drs Alawi Alsheikh-Ali and Richard Karas (Tufts University School of Medicine, Boston, MA) showed there was a "significant and linear relationship" between LDL levels achieved and risk of new cancer cases. Another study published in 2008 by the same researchers showed a similar relationship between low LDL-cholesterol levels and incident cancer.
The Tufts researchers compared 201 cancer patients against 402 healthy people; none of the participants was taking a cholesterol-lowering statin. On four separate occasions during nearly 19 years` observation, the cancer patients consistently had lower LDL levels than the healthy group, and after taking into account other possible factors, the researchers concluded that levels of LDL cholesterol were the one thing that seemed to influence the development of cancer.
(Source: American College of Cardiology 61st annual scientific session, March 25, 2012)).